PubMed Health⌕ Search

Biomedical subjects

Luis Salas Campos

Publications and source records attributed to Luis Salas Campos.

4 recordsLinked to original sources

[Preventing nosocomial infections. Dressings soaked in polyhexamethylene biguanide (PHMB)].

Polyhexamethlene biguanide (PHMB) is an antibacterial agent included in the chlorhexidine group which is active against a wide number of microorganisms including Staphylococcus Aureus Methycilin Resistant (MRSA), Vancomycin Resistant Enterococcus Faecalis (VRE) and Acinetobacter baumannii which all cause antibiotic-resistant infections. Traditionally gauze dressings have been used to cover and protect wounds although their porous structure does not constitute an efficient barrier against bacterial penetration, especially when a dressing becomes wet due to the effects of a wound oozing and draining. Recently the use of a dressing soaked in a 0.2% PHMB solution which works as a biological barrier against pathogenic agents has been introduced in clinical practice. On the one hand, this PHMB soaked dressing inhibits bacterial growth in the areas where it is applied and, on the other hand, it prevents the penetration of microorganisms through the dressing itself. Simultaneously while a PHMB soaked dressing carries out these actions, it creates an environment favorable to the proliferation of the normal flora found in the epidermis. As opposed to porous gauze dressings, a PHMB dressing remains active during 72 hours even in wet environs. Its wide anti-micro-bacterial range prevents infections in surgical, acute or chronic wounds and in any type of intra-corporal access susceptible to infection, such as by means of intravascular catheters, tracheotomies, or thoracic tubes. A PHMB dressing can also be used as a primary covering to treat a chronic wound since it does not interfere in the process of tissue reepithelization.

Anti-Bacterial Agents↗

["Ready to use" medications. A guide to limit errors when using medications].

Errors in the use of medicines are preventable incidents which may occur at any point in a chain beginning with prescription and continuing on through dispensation and administration of medicine; these errors have multi-factorial causes. Those which are potentially the most dangerous take place in hospital environment and some of them directly affect nursing personnel since they occur during the process when medicines are prepared and administered via an intravenous drip or injection. Pre-diluted medicines for intravenous use, known as "ready to use" preparations, help to reduce the amount of errors associated with the preparation and administration of medicines. These preparations guarantee the correct prescribed dose and eliminate errors related to an incorrectly labeled medicine. Moreover these ready to use medicines avoid a manipulation of the pharmaceutical product, limit the risk of particles being dragged, reduce nursing time employed in preparation of medicines substantially, and prevent accidental needle scratches during the preparation process.

Guidelines as Topic↗

[Therapeutic uses for Asian yellow-flowered crowfoot, genus Ranunculus: the case of Blastoestimulina].

Asian yellow-flower crowfoot is a plant which has been used for therapeutic purposes for more than 3000 years. Its main active ingredients are asiaticóside and madecasóside which give it a cicatrizing action as well as being a tonic for the blood. At present time, Asian yellow-flower crowfoot extract is indicated to treat ulcers, sores, scabs, and some types of burns. It is also used as a secondary helping agent to treat surgical wounds and to help skin grafts take root. Its use in the form of vaginal ovules make it be an appropriate treatment for some vaginal diseases. This extract is currently found in diverse medical preparations under the trade name "Blastoestimulina". Numerous studies are underway in the scientific field with the objective of discovering new therapeutic uses for this plant.

Burns↗

[Topical chemotherapy for the treatment of burns].

A burn is a tissue lesion which provokes different alterations that vary from topical erythema to total destruction of the structures affected. A burn always produces an alteration in the skin, a lesion in the corneal strata is sufficient to cause the skin to lose its capacity to act as a barrier. The objective the treatment for a burn has is to produce epithelization as soon as possible in order to prevent infection and to reduce functional and esthetic aftereffects. Infection is the main cause of death due to burns due to the growth of endogenous flora or due to external contamination. The use of topical chemotherapy is fundamental to prevent infections when there are deep and superficial burns or extensive intermediary burns. Centella asiatica extract has proven to be efficient in helping, maintaining and regularizing cicatrisation of skin affected by burns. Its usage combined with an antibiotic agent such as neomycin covers the bacterial spectrum for gram-positive or -negative microorganisms, guaranteeing an anti-infectious efficiency for this extract.

Administration, Topical↗